{"organizations": [], "uuid": "2e8b09bb5f6417fd94e491b7462e6c63c9b48344", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/news/media", "section_title": "Media | Reuters.com", "url": "https://www.reuters.com/article/investment-funds-berkshire-hatha/berkshire-hathaway-doubles-teva-bet-confirms-apple-purchases-idUSL2N1SM28S", "country": "US", "domain_rank": 408, "title": "Berkshire Hathaway doubles Teva bet, confirms Apple purchases", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-16T04:27:00.000+03:00", "replies_count": 0, "uuid": "2e8b09bb5f6417fd94e491b7462e6c63c9b48344"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/investment-funds-berkshire-hatha/berkshire-hathaway-doubles-teva-bet-confirms-apple-purchases-idUSL2N1SM28S", "ord_in_thread": 0, "title": "Berkshire Hathaway doubles Teva bet, confirms Apple purchases", "locations": [], "entities": {"persons": [{"name": "warren buffett", "sentiment": "negative"}, {"name": "jonathan stempel", "sentiment": "none"}], "locations": [{"name": "new york", "sentiment": "none"}], "organizations": [{"name": "apple", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "berkshire hathaway inc", "sentiment": "negative"}, {"name": "berkshire hathaway", "sentiment": "negative"}, {"name": "apple inc", "sentiment": "none"}, {"name": "g crosse", "sentiment": "none"}, {"name": "berkshire", "sentiment": "none"}, {"name": "u.s. securities and exchange commission", "sentiment": "none"}, {"name": "teva pharmaceutical industries ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 15 (Reuters) - Warren Buffett’s Berkshire Hathaway Inc on Tuesday said it has more than doubled its investment in generic drugmaker Teva Pharmaceutical Industries Ltd , and confirmed it has become Apple Inc’s second-largest shareholder.\nBerkshire said it owned about 40.5 million Teva American depositary receipts (ADRs) worth about $693 million as of March 31, up from 18.9 million ADRs three months earlier.\nThe disclosure was made in a filing with the U.S. Securities and Exchange Commission detailing Berkshire’s U.S.-listed stock holdings as of March 31.\nBerkshire also said it boosted its Apple stake to about 239.6 million shares worth more than $40 billion as of March 31, up from 165.3 million shares three months earlier. (Reporting by Jonathan Stempel in New York, editing by G Crosse)\nOur Standards: The Thomson Reuters Trust Principles. ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-16T04:27:00.000+03:00", "crawled": "2018-05-16T06:06:55.001+03:00", "highlightTitle": ""}